Table 3:

Changes in office BP and ABP at baseline and after 12-week dapagliflozin therapy (n = 83).

Baseline (mean ± SD)Week 12 (mean ± SD)Absolute change (95% CI)P
Office SBP (mmHg)139.5 ± 17.5131.7 ± 12.9−7.9 (−12.1/−3.6)<.001
Office DBP (mmHg)80.7 ± 13.676.2 ± 7.5−4.4 (−7.6/−1.3).006
24-h SBP (mmHg)128.7 ± 12.4126.4 ± 11.0−2.3 (−4.5/−0.2).032
24-h DBP (mmHg)73.2 ± 9.172.1 ± 7.5−1.1 (−2.7/0.5).169
Daytime SBP (mmHg)131.6 ± 13.2129.1 ± 11.0−2.4 (−4.8/−0.1).046
Daytime DBP (mmHg)75.7 ± 9.074.0 ± 7.9−1.7 (−3.3/−0.1).046
Nighttime SBP (mmHg)123.1 ± 13.6120.1 ± 13.3−3.0 (−5.2/−0.8).010
Nighttime DBP (mmHg)67.2 ± 11.166.1 ± 8.4−1.1 (−2.9/0.6).197
Dipping status (%)31.350.6+19.3.005
Baseline (mean ± SD)Week 12 (mean ± SD)Absolute change (95% CI)P
Office SBP (mmHg)139.5 ± 17.5131.7 ± 12.9−7.9 (−12.1/−3.6)<.001
Office DBP (mmHg)80.7 ± 13.676.2 ± 7.5−4.4 (−7.6/−1.3).006
24-h SBP (mmHg)128.7 ± 12.4126.4 ± 11.0−2.3 (−4.5/−0.2).032
24-h DBP (mmHg)73.2 ± 9.172.1 ± 7.5−1.1 (−2.7/0.5).169
Daytime SBP (mmHg)131.6 ± 13.2129.1 ± 11.0−2.4 (−4.8/−0.1).046
Daytime DBP (mmHg)75.7 ± 9.074.0 ± 7.9−1.7 (−3.3/−0.1).046
Nighttime SBP (mmHg)123.1 ± 13.6120.1 ± 13.3−3.0 (−5.2/−0.8).010
Nighttime DBP (mmHg)67.2 ± 11.166.1 ± 8.4−1.1 (−2.9/0.6).197
Dipping status (%)31.350.6+19.3.005

SD, standard deviation; DBP, diastolic blood pressure; CI, confidence interval.

Table 3:

Changes in office BP and ABP at baseline and after 12-week dapagliflozin therapy (n = 83).

Baseline (mean ± SD)Week 12 (mean ± SD)Absolute change (95% CI)P
Office SBP (mmHg)139.5 ± 17.5131.7 ± 12.9−7.9 (−12.1/−3.6)<.001
Office DBP (mmHg)80.7 ± 13.676.2 ± 7.5−4.4 (−7.6/−1.3).006
24-h SBP (mmHg)128.7 ± 12.4126.4 ± 11.0−2.3 (−4.5/−0.2).032
24-h DBP (mmHg)73.2 ± 9.172.1 ± 7.5−1.1 (−2.7/0.5).169
Daytime SBP (mmHg)131.6 ± 13.2129.1 ± 11.0−2.4 (−4.8/−0.1).046
Daytime DBP (mmHg)75.7 ± 9.074.0 ± 7.9−1.7 (−3.3/−0.1).046
Nighttime SBP (mmHg)123.1 ± 13.6120.1 ± 13.3−3.0 (−5.2/−0.8).010
Nighttime DBP (mmHg)67.2 ± 11.166.1 ± 8.4−1.1 (−2.9/0.6).197
Dipping status (%)31.350.6+19.3.005
Baseline (mean ± SD)Week 12 (mean ± SD)Absolute change (95% CI)P
Office SBP (mmHg)139.5 ± 17.5131.7 ± 12.9−7.9 (−12.1/−3.6)<.001
Office DBP (mmHg)80.7 ± 13.676.2 ± 7.5−4.4 (−7.6/−1.3).006
24-h SBP (mmHg)128.7 ± 12.4126.4 ± 11.0−2.3 (−4.5/−0.2).032
24-h DBP (mmHg)73.2 ± 9.172.1 ± 7.5−1.1 (−2.7/0.5).169
Daytime SBP (mmHg)131.6 ± 13.2129.1 ± 11.0−2.4 (−4.8/−0.1).046
Daytime DBP (mmHg)75.7 ± 9.074.0 ± 7.9−1.7 (−3.3/−0.1).046
Nighttime SBP (mmHg)123.1 ± 13.6120.1 ± 13.3−3.0 (−5.2/−0.8).010
Nighttime DBP (mmHg)67.2 ± 11.166.1 ± 8.4−1.1 (−2.9/0.6).197
Dipping status (%)31.350.6+19.3.005

SD, standard deviation; DBP, diastolic blood pressure; CI, confidence interval.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close